olaparib,apalutamide
astrazeneca,merck,janssen
['biomarker', 'prostate']
powerful words from dr. de bono underlining the need for more precise biomarkers of response in #prostatecancer exciting space to have the privilege of contributing to #esmo22 
Medical Oncologist, Chair Southern Alberta GU Tumour Group, Tom Baker Cancer Centre. Opinions are my own.